Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 21;3(1):30-38.
doi: 10.1530/RAF-21-0093. eCollection 2022 Jan 1.

Altered endometrial oestrogen-responsiveness and recurrent reproductive failure

Hannan Al-Lamee  1   2   3 , Amy Ellison  1 , Josephine Drury  1 , Christopher J Hill  1 , Andrew J Drakeley  2   3 , Dharani K Hapangama  1   2 , Nicola Tempest  1   2   3
Affiliations

Altered endometrial oestrogen-responsiveness and recurrent reproductive failure

Hannan Al-Lamee et al. Reprod Fertil. .

Abstract

Abstract: Recurrent reproductive failure (RRF) encompasses recurrent implantation failure (RIF) and recurrent pregnancy loss (RPL). These highly prevalent, distressing conditions have many unanswered questions regarding aetiology and management. Oestrogen receptor beta (ERβ) is the predominant oestrogen receptor expressed in the vascular endothelium of the endometrium during the window of implantation (WOI). The establishment of normal endometrial receptivity is integrally associated with progesterone receptor (PR). Therefore, we aimed to investigate whether women with RRF have clinical, type-specific endometrial aberrations of ERβ, PR and Ki-67 expression during the WOI. Thirty-eight endometrial biopsies were collected; 29 RRF (10 RIF, 9 recurrent loss of early pregnancy (RLEP) and 10 recurrent fetal loss (RFL)) and 9 fertile controls (FC). Within RIF, RLEP and RFL groups, the perivascular compartment showed significantly lower levels of ERβ vs FC (P = 0.02, P = 0.03 and P = 0.01, respectively). Vascular endothelium also displayed significantly lower levels of ERβ within RIF and RFL cohorts vs FC (P = 0.03 and P = 0.003). The expression of Ki-67 was significantly lower within vascular endothelium of all RRF; RIF (P = 0.02), RLEP (P = 0.02) and RFL (P <0.01). PR was significantly reduced (P <0.001) in the perivascular area of women with RIF. These findings provide novel insights into biological correlates of clinical subtypes of RRF. The endometrium of women with RRF display significantly altered levels of ERβ, PR and Ki-67 during the WOI, furthering our understanding of the defective endometrial phenotype of women suffering from RRF, with possible impaired glandular function, angiogenesis and decidualisation.

Lay summary: Recurrent reproductive failure (RRF) refers to a group of devastating conditions with many unanswered questions regarding their causes and treatment options. The lining of the womb, the endometrium, is primed and suitable for successful embryo implantation for a short time during the menstrual cycle; the window of implantation (WOI). Oestrogen is a key hormone that plays an important role in regulating the endometrium and its effects are exerted via two oestrogen receptor subtypes. Oestrogen receptor beta (ERβ) is the main oestrogen receptor present during the WOI. Progesterone receptor allows the other main hormone, progesterone, to influence the endometrial activity and Ki-67 reflects the proliferative activity of the cells within the endometrium. We investigated the expression of these markers in endometrial samples collected from women with RRF and proven fertility. We found that the endometrium of women with RRF has significantly lower levels of ERβ and Ki-67 during the WOI, possibly leading to unsuccessful pregnancies.

Keywords: endometrium; oestrogen-receptor beta; recurrent implantation failure; recurrent pregnancy loss; recurrent reproductive failure; window of implantation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative micrographs demonstrating (A) ERβ, (B) PR and (C) Ki-67 immunostaining during the window of implantation in the endometrium of fertile control, recurrent implantation failure (RIF), recurrent loss of early pregnancy (RLEP) and recurrent fetal loss (RFL) patients. Representative images illustrate the distribution of immunostaining across glandular, stromal, perivascular and vascular compartments. Scale bars 60 µm throughout (400× magnification).
Figure 2
Figure 2
Immunostaining scores for ERβ within the (A) glandular epithelium, (B) perivascular cells, (C) vascular endothelium, (D) stromal cells and (E) luminal epithelium of the endometrium of fertile control, recurrent implantation failure (RIF), recurrent loss of early pregnancy (RLEP) and recurrent fetal loss (RFL) patients.
Figure 3
Figure 3
Immunostaining scores for PR within the (A) glandular epithelium, (B) perivascular cells, (C) vascular endothelium, (D) stromal cells and (E) luminal epithelium of the endometrium of fertile control, recurrent implantation failure (RIF), recurrent loss of early pregnancy (RLEP) and recurrent fetal loss (RFL) patients.
Figure 4
Figure 4
Immunostaining scores for Ki-67 within the (A) glandular epithelium, (B) perivascular cells, (C) vascular endothelium, (D) stromal cells and (E) luminal epithelium of the endometrium of fertile control, recurrent implantation failure (RIF), recurrent loss of early pregnancy (RLEP) and recurrent fetal loss (RFL) patients.
See this image and copyright information in PMC

References

    1. Alnafakh R, Saretzki G, Midgley A, Flynn J, Kamal AM, Dobson L, Natarajan P, Stringfellow H, Martin-Hirsch P, DeCruze SBet al.2021Aberrant dyskerin expression is related to proliferation and poor survival in endometrial cancer. Cancers 13 E273. (10.3390/cancers13020273) - DOI - PMC - PubMed
    1. Arora R, Fries A, Oelerich K, Marchuk K, Sabeur K, Giudice LC, Laird DJ.2016Insights from imaging the implanting embryo and the uterine environment in three dimensions. Development 1434749–4754. (10.1242/dev.144386) - DOI - PMC - PubMed
    1. Cimadomo D, Craciunas L, Vermeulen N, Vomstein K, Toth B.2021Definition, diagnostic and therapeutic options in recurrent implantation failure: an international survey of clinicians and embryologists. Human Reproduction 36305–317. (10.1093/humrep/deaa317) - DOI - PubMed
    1. Critchley HO, Brenner RM, Henderson TA, Williams K, Nayak NR, Slayden OD, Millar MR, Saunders PT.2001Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. Journal of Clinical Endocrinology and Metabolism 861370–1378. (10.1210/jcem.86.3.7317) - DOI - PubMed
    1. Curtis SW, Clark J, Myers P, Korach KS.1999Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus. PNAS 963646–3651. (10.1073/pnas.96.7.3646) - DOI - PMC - PubMed

Publication types